Sodium Chloride 0.9% Intravenous Solution — Competitive Intelligence Brief

Sodium Chloride 0.9% Intravenous Solution (Sodium Chloride 0.9% Intravenous Solution) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Electrolyte replacement solution. Area: Fluid and electrolyte management.

marketed Electrolyte replacement solution Fluid and electrolyte management Small molecule

Target snapshot

Sodium Chloride 0.9% Intravenous Solution (Sodium Chloride 0.9% Intravenous Solution) — Department of Medical Services Ministry of Public Health of Thailand. Sodium chloride 0.9% restores and maintains electrolyte balance and fluid volume in the body by providing isotonic saline solution.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Sodium Chloride 0.9% Intravenous Solution TARGET	Sodium Chloride 0.9% Intravenous Solution	Department of Medical Services Ministry of Public Health of Thailand	marketed	Electrolyte replacement solution
Plegisol In Plastic Container	Calcium Chloride	Pfizer	marketed	Electrolyte replacement solution	Electrolyte balance and fluid homeostasis	1971-01-01
NaCl 9% isotonic	NaCl 9% isotonic	Centre Hospitalier Universitaire de Nice	marketed	Electrolyte replacement solution
normal saline - injection	normal saline - injection	Montefiore Medical Center	marketed	Crystalloid fluid / Electrolyte replacement solution
serum physiologic	serum physiologic	TC Erciyes University	marketed	Electrolyte replacement solution
Sodium Chloride, (24)NaCl 0,9%	Sodium Chloride, (24)NaCl 0,9%	University of Oulu	marketed	Electrolyte replacement solution
% 0.9 Saline solution	% 0.9 Saline solution	Kecioren Education and Training Hospital	marketed	Crystalloid fluid / Electrolyte replacement solution

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Electrolyte replacement solution class)

1. Baxter Healthcare Corporation · 1 drug in this class
2. Centre Hospitalier Universitaire Dijon · 1 drug in this class
3. Centre Hospitalier Universitaire de Nice · 1 drug in this class
4. Department of Medical Services Ministry of Public Health of Thailand · 1 drug in this class
5. Federico II University · 1 drug in this class
6. Hospital Universitari Vall d'Hebron Research Institute · 1 drug in this class
7. Nepal Health Research Council · 1 drug in this class
8. Pfizer · 1 drug in this class
9. Shanghai Hengrui Pharmaceutical Co., Ltd. · 1 drug in this class
10. TC Erciyes University · 1 drug in this class